Sort
39,280 grants matching “leukemia”
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,642Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2021 · HD
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
$1,225,614Xiaolei Wang · Tulane University Of Louisiana · R01 · FY2020 · HD
MolecularCellular Regulation of Hematopoiesis
$1,225,037Jonathan R Keller · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
WHOLE GENOME SEQUENCING OF MYELODYSPLASTIC SYNDROMES
$1,224,842Timothy A Graubert · Washington University · RC2 · FY2009 · HL
Mechanistic investigation of therapies for Down Syndrome Regression Disorder
$1,224,805Joaquin M. Espinosa · University Of Colorado Denver · R33 · FY2025 · HD
Breast Cancer Risk and Molecular Change After Chernobyl
$1,224,761Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2009 · CA
Lymphoma Disease Discovery and Definition
$1,224,381Elaine Jaffe · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Zebrafish Models of Cancer
$1,223,960Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Comparative Genomics Analysis Unit Research
$1,223,958James C Mullikin · National Human Genome Research Institute · ZIA · FY2015 · HG
Administrative Core
$1,221,951Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2022 · CA
Genetic Aspects Of Viral Oncogenesis In Inbred Strains and Wild Mouse Species
$1,221,899Christine Kozak · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
$1,221,450Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · U10 · FY2017 · CA
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
$1,221,450Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · U10 · FY2014 · CA
Lead Academic Participating Site for the Development and Conduct of NCTN Trials
$1,221,450Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · U10 · FY2015 · CA
SEARCH FOR SELECTIVE THERAPY OF CML
$1,221,303Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Hematopoietic Stem Cell Transplant for GATA2 Deficiency
$1,220,934Dennis Hickstein · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Studies of Populations Exposed to Environmental Sources of Radiation
$1,219,562Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Clinical, Immunological and Genetic Analyses of ALPS and Related Immunedysregulatory Disorders
$1,217,919V Koneti Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
CANCER AND INFLAMMATION GENETICS
$1,216,954Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Dynamic State Space Modeling of Cancer Cell Response to Therapy
$1,216,672Garry P Nolan · University Of Southern California · U54 · FY2009 · CA
Mechanisms of non-classical multidrug resistance in cancer
$1,215,165Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,214,404Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2012 · HL
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$1,212,592Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2009 · CA
Nuclear Structure and Gene Expression
$1,212,440Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · CA
PROGRAM PROJECT IN ALLOGENEIC STEM CELL TRANSPLANTATION
$1,212,062Dana-Farber Cancer Institute · P01 · FY2003 · AI